Literature DB >> 24130125

High frequency strand slippage mutations in CTCF in MSI-positive endometrial cancers.

Israel Zighelboim, David G Mutch, Amy Knapp, Li Ding, Mingchao Xie, David E Cohn, Paul J Goodfellow.   

Abstract

Tumors with defective mismatch repair acquire large numbers of strand slippage mutations including frameshifts in coding sequence repeats. We identified a mutational hotspot, p.T204fs, in the insulator-binding protein (CTCF) in MSI-positive endometrial cancers. Although CTCF was described as a significantly mutated gene by the endometrial cancer TCGA, the A₇ track variants leading to T204 frameshifts were not reported. Reanalysis of TCGA data using Pindel revealed frequent T204fs mutations, confirming CTCF is an MSI target gene and revealed the same frameshifts in tumors with intact mismatch repair. We show that T204fs transcripts are subject to nonsense-mediated decay and as such, T204fs mutations are unlikely to act as dominant negatives. The spectrum and pattern of mutations observed is consistent with CTCF acting as a haploinsufficient tumor suppressor.
© 2013 WILEY PERIODICALS, INC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24130125      PMCID: PMC3946358          DOI: 10.1002/humu.22463

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  21 in total

1.  Haploinsufficiency of ARID1B, a member of the SWI/SNF-a chromatin-remodeling complex, is a frequent cause of intellectual disability.

Authors:  Juliane Hoyer; Arif B Ekici; Sabine Endele; Bernt Popp; Christiane Zweier; Antje Wiesener; Eva Wohlleber; Andreas Dufke; Eva Rossier; Corinna Petsch; Markus Zweier; Ina Göhring; Alexander M Zink; Gudrun Rappold; Evelin Schröck; Dagmar Wieczorek; Olaf Riess; Hartmut Engels; Anita Rauch; André Reis
Journal:  Am J Hum Genet       Date:  2012-03-09       Impact factor: 11.025

2.  Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability.

Authors:  Vessela Vassileva; Anna Millar; Laurent Briollais; William Chapman; Bharati Bapat
Journal:  Cancer Res       Date:  2002-07-15       Impact factor: 12.701

3.  Analysis of MSH3 in endometrial cancers with defective DNA mismatch repair.

Authors:  E M Swisher; D G Mutch; T J Herzog; J S Rader; L D Kowalski; A Elbendary; P J Goodfellow
Journal:  J Soc Gynecol Investig       Date:  1998 Jul-Aug

Review 4.  Genetic and epigenetic networks in intellectual disabilities.

Authors:  Hans van Bokhoven
Journal:  Annu Rev Genet       Date:  2011-09-09       Impact factor: 16.830

5.  Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome.

Authors:  Yoshinori Tsurusaki; Nobuhiko Okamoto; Hirofumi Ohashi; Tomoki Kosho; Yoko Imai; Yumiko Hibi-Ko; Tadashi Kaname; Kenji Naritomi; Hiroshi Kawame; Keiko Wakui; Yoshimitsu Fukushima; Tomomi Homma; Mitsuhiro Kato; Yoko Hiraki; Takanori Yamagata; Shoji Yano; Seiji Mizuno; Satoru Sakazume; Takuma Ishii; Toshiro Nagai; Masaaki Shiina; Kazuhiro Ogata; Tohru Ohta; Norio Niikawa; Satoko Miyatake; Ippei Okada; Takeshi Mizuguchi; Hiroshi Doi; Hirotomo Saitsu; Noriko Miyake; Naomichi Matsumoto
Journal:  Nat Genet       Date:  2012-03-18       Impact factor: 38.330

6.  De novo mutations in the genome organizer CTCF cause intellectual disability.

Authors:  Anne Gregor; Martin Oti; Evelyn N Kouwenhoven; Juliane Hoyer; Heinrich Sticht; Arif B Ekici; Susanne Kjaergaard; Anita Rauch; Hendrik G Stunnenberg; Steffen Uebe; Georgia Vasileiou; André Reis; Huiqing Zhou; Christiane Zweier
Journal:  Am J Hum Genet       Date:  2013-06-06       Impact factor: 11.025

7.  A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function.

Authors:  Sonia A Melo; Santiago Ropero; Catia Moutinho; Lauri A Aaltonen; Hiroyuki Yamamoto; George A Calin; Simona Rossi; Agustin F Fernandez; Fatima Carneiro; Carla Oliveira; Bibiana Ferreira; Chang-Gong Liu; Alberto Villanueva; Gabriel Capella; Simo Schwartz; Ramin Shiekhattar; Manel Esteller
Journal:  Nat Genet       Date:  2009-02-15       Impact factor: 38.330

8.  Pten is essential for embryonic development and tumour suppression.

Authors:  A Di Cristofano; B Pesce; C Cordon-Cardo; P P Pandolfi
Journal:  Nat Genet       Date:  1998-08       Impact factor: 38.330

9.  Microsatellite instability in sporadic endometrial carcinoma.

Authors:  B D Duggan; J C Felix; L I Muderspach; D Tourgeman; J Zheng; D Shibata
Journal:  J Natl Cancer Inst       Date:  1994-08-17       Impact factor: 13.506

10.  DICER1 mutations in familial pleuropulmonary blastoma.

Authors:  D Ashley Hill; Jennifer Ivanovich; John R Priest; Christina A Gurnett; Louis P Dehner; David Desruisseau; Jason A Jarzembowski; Kathryn A Wikenheiser-Brokamp; Brian K Suarez; Alison J Whelan; Gretchen Williams; Dawn Bracamontes; Yoav Messinger; Paul J Goodfellow
Journal:  Science       Date:  2009-06-25       Impact factor: 47.728

View more
  16 in total

1.  Novel genetic targets in endometrial cancer.

Authors:  Daphne W Bell
Journal:  Expert Opin Ther Targets       Date:  2014-04-21       Impact factor: 6.902

Review 2.  The mutational landscape of endometrial cancer.

Authors:  Bo Hong; Matthieu Le Gallo; Daphne W Bell
Journal:  Curr Opin Genet Dev       Date:  2015-01-23       Impact factor: 5.578

3.  The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas.

Authors:  Matthieu Le Gallo; Meghan L Rudd; Mary Ellen Urick; Nancy F Hansen; Maria J Merino; David G Mutch; Paul J Goodfellow; James C Mullikin; Daphne W Bell
Journal:  Cancer       Date:  2017-09-21       Impact factor: 6.860

4.  Absence of DICER1, CTCF, RPL22, DNMT3A, TRRAP, IDH1 and IDH2 hotspot mutations in patients with various subtypes of ovarian carcinomas.

Authors:  Yang Zou; Mei-Zhen Huang; Fa-Ying Liu; Bi-Cheng Yang; Li-Qun Wang; Feng Wang; Xiao-Hong Yu; Lei Wan; Xi-DI Wan; Xiao-Yun Xu; Wei Li; Ou-Ping Huang; Ming He
Journal:  Biomed Rep       Date:  2014-11-07

5.  Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancer.

Authors:  Floor J Backes; Christopher J Walker; Paul J Goodfellow; Erinn M Hade; Garima Agarwal; David Mutch; David E Cohn; Adrian A Suarez
Journal:  Gynecol Oncol       Date:  2016-03-10       Impact factor: 5.482

6.  MonoSeq Variant Caller Reveals Novel Mononucleotide Run Indel Mutations in Tumors with Defective DNA Mismatch Repair.

Authors:  Christopher J Walker; Mario A Miranda; Matthew J O'Hern; James S Blachly; Cassandra L Moyer; Jennifer Ivanovich; Karl W Kroll; Ann-Kathrin Eisfeld; Caroline E Sapp; David G Mutch; David E Cohn; Ralf Bundschuh; Paul J Goodfellow
Journal:  Hum Mutat       Date:  2016-08-08       Impact factor: 4.878

7.  Patterns of CTCF and ZFHX3 Mutation and Associated Outcomes in Endometrial Cancer.

Authors:  Christopher J Walker; Mario A Miranda; Matthew J O'Hern; Joseph P McElroy; Kevin R Coombes; Ralf Bundschuh; David E Cohn; David G Mutch; Paul J Goodfellow
Journal:  J Natl Cancer Inst       Date:  2015-09-01       Impact factor: 13.506

8.  MAX Mutations in Endometrial Cancer: Clinicopathologic Associations and Recurrent MAX p.His28Arg Functional Characterization.

Authors:  Christopher J Walker; Craig M Rush; Paola Dama; Matthew J O'Hern; Casey M Cosgrove; Jessica L Gillespie; Roman A Zingarelli; Blair Smith; Maggie E Stein; David G Mutch; Reena Shakya; Chia-Wen Chang; Karuppaiyah Selvendiran; Jonathan W Song; David E Cohn; Paul J Goodfellow
Journal:  J Natl Cancer Inst       Date:  2018-05-01       Impact factor: 13.506

Review 9.  CTCF and CTCFL in cancer.

Authors:  Roxanne E Debaugny; Jane A Skok
Journal:  Curr Opin Genet Dev       Date:  2020-04-22       Impact factor: 5.578

10.  Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.

Authors:  Erling A Hoivik; Kanthida Kusonmano; Mari K Halle; Anna Berg; Elisabeth Wik; Henrica M J Werner; Kjell Petersen; Anne M Oyan; Karl-Henning Kalland; Camilla Krakstad; Jone Trovik; Martin Widschwendter; Helga B Salvesen
Journal:  Oncotarget       Date:  2014-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.